RumeyzaKazancioglu TürkiyeBezmialem Vakif University

She graduated from Istanbul University, Istanbul Faculty of Medicine in 1991, and completed her Internal Medicine Residency and Nephrology fellowship at the same faculty until 2001. She is a former ISN fellow, currently working at Bezmialem Vakif University School of Medicine Division Nephrology. Prof. Kazancıoğlu has published many national and international articles, books and book chapters. Her main interests are in PD, disaster nephrology, CKD and ESKD.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Hands on Big Data Mining for the Nephrologist in 2024 SK1001 HeatherAscani Chairperson United StatesUniversity of Michigan KatherineTuttle Chairperson United StatesUniversity of Washington School of Medicine, Division of Nephrology MatthiasKretzler Chairperson United StatesUniversity of Michigan Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse VijiNair Speaker United StatesUniversity of Michigan Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI MatthiasKretzler Speaker United StatesUniversity of Michigan The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University Panel Discussion Hall C1
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 AgnesFogo Chairperson United States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja Hall A
12:15 p.m. 1:15 p.m.	Transplant Tourism in My Clinic: What Should I Do? ISN-DICG Joint Session CHAL1001 Domingo Casadei Chairperson drdomingocasadei@gmail.com VivekanandJha Chairperson IndiaGeorge Institute for Global Health India How to Achieve Transparent and Regulated Organ Donation and Transplantation Maria AmaliaMatamoros Speaker Costa RicaCaja Costarricense del Seguro social Non-resident Foreigners in Argentina: Legal Framework to Prevent Transplant Tourism LilianaBisigniano Speaker lbisigniano@incucai.gov.arArgentinaLiliana Bisigniano MD How to Handle Cases of Presumed Transplant Tourism KenSakai Speaker kensakai@med.toho-u.ac.jpJapanDepartment of Nephrology, Toho University Omori Medical Center Q and A Hall C1
4:30 p.m. 5:30 p.m.	New Developments in CKD Epidemiology Research IK1001 MaartenTaal Chairperson United KingdomUniversity of Nottingham RobertoPecoits Filho Chairperson United StatesArbor Research Collaborative for Health Big Data Lab LAB-01 Patient-reported Outcome Measures: How Do Patients Experience CKD? AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care Trial Simulation Using Observational Data AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgUnited StatesArbor Research Collaborative for Health Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges DorotheaNitsch Speaker United KingdomLondon School of Hygiene & Tropical Medicine Q and A Hall C4

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	Hot Digests of Kidney Inflammation and Immunity: ISN-JSN Joint Session LF2002 AlejandraQuevedo Smuclir Chairperson alejandra.s.quevedo@gmail.comArgentinaSAN CarmenTzanno Branco Martins Chairperson BrazilSLANH, ISN SaoriNishio Chairperson saorin@med.hokudai.ac.jpJapan Update of Glomerulonephritis FernandoFervenza Speaker fervenza.fernando@mayo.eduUnited StatesMayo Clinic Inflammation and Metabolic Kidney Disease JunWada Speaker junwada@okayama-u.ac.jpJapanOkayama University A Novel Treatment Targeting Kidney Inflammation Maria JoseSoler Speaker SpainHospital del Vall d´Hebron Controlling Kidney Inflammation Through the Nervous System ShinjiTanaka Speaker shitanaka@m.u-tokyo.ac.jpJapanDivision of Nephrology and Endocrinology, the University of Tokyo Hospital Q and A Hall C3
10:30 a.m. 11 a.m.	Nephrology in Jeopardy: A Sustainable Kidney Care Quiz SPOT-12 BrendanSmyth Spotlight Chairperson brendan.smyth@sydney.edu.auAustralia LetiziaDe Chiara Spotlight Chairperson letizia.dechiara@unifi.itItalyDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence UgochiOnu Spotlight Chairperson Nigeria Spotlight Stage 1 (exhibition hall)
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) PL3 Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/ Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	Natural and Man-made Disasters and Kidney Care. ISN-ERA Special Lecture BKH03 IfeomaUlasi Chairperson NigeriaCollege of Medicine, University of Nigeria VictorFrajewicki Chairperson vfraje@clalit.org.ilIsraelDepartment of Nephrology and Hypertension, Carmel Medical Center, Haifa The Next Pandemic - What Has the Nephrology Community Learned From COVID-19? RaulLombardi Speaker lombardi.raul2@gmail.comUruguayDepartment of Nephrology, Schoole of Medicine, Uni Challenges in Nephrological Care During Difficult Situations: Lessons From Venezuela Lorendiz Pamela Ronca Chacare Speaker lorendiz.ronca@gmail.comVenezuelaSociedad Venezolana de Nefrología Kidney Care During Earthquakes: Lessons Learned From Turkey RumeyzaKazancioglu Speaker drkazancioglu@yahoo.comTürkiyeBezmialem Vakif University Provision of Renal Care During Man-made Disasters and Armed Conflicts: A Challenging Proposition RobertNajem Speaker robertnajem@yahoo.frLebanonLebanese University, Faculty of Medical Sciences. Q and A Hall D
3 p.m. 4 p.m.	Transplant-Onconephrology CHAL04 DarioRoccatello Chairperson dario.roccatello@unito.itItaly GayatriNair Chairperson gnair1@northwell.eduUnited StatesNorthwell Health, NY MarianoArriola Chairperson marianoarriola@hotmail.comArgentinaSAT, SAN, Facultad de Medicina (UNL) Use of Immunotherapy in Patients With Organ Transplants NaokaMurakami Speaker nmurakami1@bwh.harvard.eduUnited StatesBrigham and Women\'s Hospital, Harvard Medical S Transplantation Outcomes in Recipients with History of Cancer GermaineWong Speaker AustraliaUniversity of Sydney Novel Strategies for Enhanced Organ Preservation during Machine Perfusion TobiasHuber Speaker GermanyUniversity Medical Center Hamburg-Eppendorf Q and A Hall E
3:50 p.m. 5:40 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Advancing Accessibility in Kidney Health - Towards Sustainable Solutions PF2 IfeomaUlasi Chairperson NigeriaCollege of Medicine, University of Nigeria Nelson AlbertoCastro Moderator trischt19@gmail.comArgentina Accessibility to CKD Diagnosis: Focus on CKDu (Chronic Kidney Disease of Unknown Origin) and Advancements in Diagnostic Approaches RamonGarcia Trabanino Speaker rgtrab@gmail.comEl SalvadorSLANH Latin American Dialysis and Renal Transplantation Registry: Updates and Progress MariaGonzalez Speaker registro@slanh.netUruguaySLANH Special Situations in Argentina: Addressing the Challenges Faced by Individuals on Dialysis Without a Diagnosis in the Argentinian Registry GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology Cardiovascular and Renal Risk Factors in Argentinian First Nations: A Study of Qom and Wichi Indigenous Groups Maria Eugenia VictoriaBianchi Speaker bianchimaria@me.comArgentinaISN. SAN. Accessibility to Substitution Treatment in Latin America AlejandroFerreiro-Fuentes Speaker UruguayCentro de Nefrología. Universidad de la República, Accessibility to Programs of Prevention, and Early Detection and Treatment of Kidney Disease in Latin America Alfonso MartinCueto Manzano Speaker a_cueto_manzano@hotmail.comMexicoUnidad de Investigación Médica en Enfermedades Ren Break Panel Discussion and Closing Remarks by Valerie Luyckx, University of Zurich, Switzerland Hall C2
4:30 p.m. 5:30 p.m.	Designing Smart Clinical Trials SK05 DebbieGipson Chairperson debbie.gipson@nih.govUnited StatesNational Institutes of Health/NIDDK JonathanBarratt Chairperson United KingdomUniversity of Leicester, Leicester, UK Patients Subphenotyping: The Example of Diabetic Kidney Disease John CijiangHe Speaker cijiang.he@mssm.eduUnited StatesIcahn School of Medicine at Mount Sinai Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan Targeted Approaches in Clinical Trial Design HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall D

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10:30 a.m.	Hi Aldo, What's New? Advances in Aldosterone in Health and Disease IK04 CarlosSchreck Chairperson carlos.schreck@gmail.comArgentinaHospital Italiano de Buenos Aires- Nephrology KellyHaughton Chairperson kidneydoctorpanama@gmail.comPanamaSLANH, Panama Why Are Fewer Than I% Of Hypertensive Patients Ever Screened For Primary Aldosteronism? John Funder Speaker John.Funder@hudson.org.auAustraliaThe Hudson Institute of Medical Research Clayton 3168 Victoria Australia; Monash University, Clayton 3600 Victoria Australia Aldosterone and Disease JordanaCohen Speaker jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania New Trials Using Aldosterone Synthese Blockade MichelAzizi Speaker michel.azizi@aphp.frFranceUniversité Paris Cité, Hypertension department, Hô Targeting MR for Heart and Kidney Protection HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall E
9 a.m. 10:30 a.m.	Clinical Management of Glomerulonephritis (GN) SK06 Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ValeriaAlberton Chairperson vgalberton@gmail.comArgentinaHospital Fernandez/ Hospital El Cruce Updates on IgAN Management HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Membranous GN Classification and Management PierreRonco Speaker FranceHôpital Tenon MPGN Updates SanjeevSethi Speaker United StatesMayo Clinic Managing Vasculitis RobertaFenoglio Speaker roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco Q and A Hall A
11 a.m. 12:15 p.m.	Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy) PL4 AlessiaFornoni Chairperson United StatesUniversity of Miami LizLightstone Chairperson United KingdomImperial College London MasaomiNangaku Chairperson Japan Acceptance Speech: Bywaters Award MotokoYanagita Speaker JapanKyoto University Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture EleFerrannini Speaker eleferrannini@gmail.comItalyUniversity of Pisa ELP2 Graduation MasaomiNangaku Speaker Japan Hall A
12:30 p.m. 1:30 p.m.	Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? IK05 MarceloOrías Chairperson marcelo.orias@gmail.comArgentina MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS TaraChang Speaker tichang@stanford.eduUnited StatesStanford University Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS JordanaCohen Speaker jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania Hall A